Acute myelogenous leukemia (AML) stem cell subpopulations, known as CD34+/CD- cells, were also shown to have high expression levels of the breast cancer resistance protein (BCRP-ABCG2 protein), which was initiated to be actively implicated in drug efflux [9]. Here, ABCG2 is linked to acute myeloid leukemia.